Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Beate Cornelia Beinvogl, M.D.

Concepts (69)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Irritable Bowel Syndrome220214541.000 Why?
Duodenitis12021200.770 Why?
Gastritis220241990.710 Why?
Abdominal Pain5202410700.680 Why?
Hemiplegia120161370.510 Why?
Muscle Hypotonia120161660.480 Why?
Quadriplegia120162270.470 Why?
Gastrointestinal Diseases2202012040.430 Why?
Constipation120175700.410 Why?
Gastroenterology120175930.370 Why?
Insurance, Health1202125180.310 Why?
Health Expenditures1202123960.300 Why?
Guideline Adherence1201722410.280 Why?
Patient Acceptance of Health Care1202132350.280 Why?
Combined Modality Therapy1201885590.260 Why?
Pediatrics1201736280.200 Why?
Quarantine120241860.190 Why?
Child112024809600.180 Why?
Bile Acids and Salts120213990.160 Why?
Adolescent82024892440.140 Why?
Communicable Disease Control120218570.120 Why?
Feces1202115100.120 Why?
Radiography, Abdominal120175410.120 Why?
Diarrhea1202113200.120 Why?
Autoimmune Diseases1202422580.100 Why?
Anxiety2202446720.100 Why?
Quality of Life22024135100.090 Why?
Cost of Illness1202119600.090 Why?
Health Care Surveys1201724370.090 Why?
Cross-Sectional Studies22021263950.080 Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors120123250.080 Why?
Biological Products120189470.080 Why?
Male920243652030.080 Why?
Prospective Studies42024549620.080 Why?
Antirheumatic Agents1201813810.080 Why?
Female820243975150.070 Why?
Humans1320247689700.070 Why?
Child, Preschool22018426830.060 Why?
Boston1201793770.060 Why?
Retrospective Studies32024819030.050 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201215600.050 Why?
Clinical Competence1201748600.050 Why?
Diagnosis, Differential12016130210.050 Why?
Practice Guidelines as Topic1201774600.040 Why?
Cohort Studies12021418080.040 Why?
Cell Differentiation12012116840.030 Why?
Infant12016365560.030 Why?
Perception1202012090.030 Why?
Pandemics2202487490.030 Why?
Disease Outbreaks1202117610.020 Why?
Treatment Outcome12018654800.020 Why?
Hep G2 Cells120123780.020 Why?
Jurkat Cells120127390.020 Why?
Microarray Analysis120127550.020 Why?
Gene Expression Regulation, Leukemic120126580.020 Why?
Drug Evaluation, Preclinical1201213400.020 Why?
Adult120212238510.020 Why?
Parents1202035970.020 Why?
Severity of Illness Index12024159510.020 Why?
Tumor Cells, Cultured1201261310.010 Why?
Neoplasm Invasiveness1201236290.010 Why?
Up-Regulation1201241480.010 Why?
RNA, Small Interfering1201234330.010 Why?
Follow-Up Studies12024393940.010 Why?
Cell Survival1201257930.010 Why?
Incidence12018215470.010 Why?
Apoptosis1201295270.010 Why?
Gene Expression Profiling1201295490.010 Why?
Risk Factors12018749760.010 Why?
Beinvogl's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.